Table of Contents Author Guidelines Submit a Manuscript
Interdisciplinary Perspectives on Infectious Diseases
Volume 2012, Article ID 626838, 13 pages
http://dx.doi.org/10.1155/2012/626838
Review Article

Developments in Diagnosis and Antileishmanial Drugs

1Amity Institute of Biotechnology, Amity University Uttar Pradesh, Sector 125, Noida 201303, India
2Amity Institute of Microbial Biotechnology, Amity University Uttar Pradesh, Sector 125, Noida 201303, India

Received 1 June 2012; Revised 7 September 2012; Accepted 11 September 2012

Academic Editor: Eliete Caló Romero

Copyright © 2012 Prachi Bhargava and Rajni Singh. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Pink, A. Hudson, M. A. Mouriès, and M. Bendig, “Opportunities and challenges in antiparasitic drug discovery,” Nature Reviews Drug Discovery, vol. 4, no. 9, pp. 727–740, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. H. K. Majumder, B. B. Das, and A. Ganguly, “DNA topoisomerases of Leishmania: the Potential targets for anti-leishmanial therapy,” Advances in Experimental Medicine and Biology, vol. 625, pp. 103–115, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. WHO, The world health report—reducing risks, promoting healthy life, World Health Organization, Geneva, Switzerland, 2002.
  4. J. Alvar, S. Yactayo, and C. Bern, “Leishmaniasis and poverty,” Trends in Parasitology, vol. 22, no. 12, pp. 552–557, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Feasey, M. Wansbrough-Jones, D. C. W. Mabey, and A. W. Solomon, “Neglected tropical diseases,” British Medical Bulletin, vol. 93, no. 1, pp. 179–200, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Desjeux, “Leishmaniasis: current situation and new perspectives,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 27, no. 5, pp. 305–318, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. TDR/WHO, “Leishmaniasis,” 2012, http://www.who.int/tdr/diseases/leish/info/en/index.html.
  8. Leishmaniasis Control, 2007, http://www.who.int/topics/leishmaniasis/en/.
  9. J. Alvar, I. D. Velez, C. Bern et al., “Leishmaniasis worldwide and global estimates of its incidence,” PloS One, vol. 7, no. 5, pp. e35671–e356712.
  10. B. L. Herwaldt, “Leishmaniasis,” The Lancet, vol. 354, no. 9185, pp. 1191–1199, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. H. W. Murray, J. Pépin, T. B. Nutman, S. L. Hoffman, and A. A. F. Mahmoud, “Recent advances: tropical medicine,” British Medical Journal, vol. 320, no. 7233, pp. 490–494, 2000. View at Google Scholar · View at Scopus
  12. P. J. Guerin, P. Olliaro, S. Sundar et al., “Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda,” Lancet Infectious Diseases, vol. 2, no. 8, pp. 494–501, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Berhe, D. Wolday, A. Hailu et al., “HIV viral load and response to antileishmanial chemotherapy in co-infected patients,” AIDS, vol. 13, no. 14, pp. 1921–1925, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Seifert, F. J. Pérez-Victoria, M. Stettler et al., “Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo,” International Journal of Antimicrobial Agents, vol. 30, no. 3, pp. 229–235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Cupolillo, L. R. Brahim, C. B. Toaldo et al., “Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil,” Journal of Clinical Microbiology, vol. 41, no. 7, pp. 3126–3132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Dereure, J. A. Rioux, M. Gallego et al., “Leishmania tropica in Morocco: infection in dogs,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 85, no. 5, p. 595, 1991. View at Google Scholar · View at Scopus
  17. J. Dereure, J. A. Rioux, A. Khiami, F. Pratlong, J. Périères, and A. Martini, “Ecoepidemiology of leishmaniases in Syria. 2—Presence, in dogs, of Leishmania infantum Nicolle and Leishmania tropica (Wright) (Kinetoplastida-Trypanonomatidae),” Annales de Parasitologie Humaine et Comparee, vol. 66, no. 6, pp. 252–255, 1991. View at Google Scholar · View at Scopus
  18. H. Yahia, P. D. Ready, A. Hamdani, J. M. Testa, and N. Guessous-Idrissi, “Regional genetic differentiation of Phlebotomus sergenti in three Moroccan foci of cutaneous leishmaniasis caused by Leishmania tropica,” Parasite, vol. 11, no. 2, pp. 189–199, 2004. View at Google Scholar · View at Scopus
  19. R. Reithinger, J. C. Dujardin, H. Louzir, C. Pirmez, B. Alexander, and S. Brooker, “Cutaneous leishmaniasis,” Lancet Infectious Diseases, vol. 7, no. 9, pp. 581–596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. P. A. Bates, “Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies,” International Journal for Parasitology, vol. 37, no. 10, pp. 1097–1106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. M. E. Rogers, T. Ilg, A. V. Nikolaev, M. A. J. Ferguson, and P. A. Bates, “Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG,” Nature, vol. 430, no. 6998, pp. 463–467, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Handman and D. V. R. Bullen, “Interaction of Leishmania with the host macrophage,” Trends in Parasitology, vol. 18, no. 8, pp. 332–334, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. R. J. S. Burchmore and M. P. Barrett, “Life in vacuoles—nutrient acquisition by Leishmania amastigotes,” International Journal for Parasitology, vol. 31, no. 12, pp. 1311–1320, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Desjeux, “Leishmaniasis: current situation and new perspectives,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 27, no. 5, pp. 305–318, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. Collin, P. G. Coleman, K. Ritmeijer, and R. N. Davidson, “Unseen Kala-azar deaths in south Sudan (1999-2002),” Tropical Medicine and International Health, vol. 11, no. 4, pp. 509–512, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. P. Singh, D. C. S. Reddy, M. Rai, and S. Sundar, “Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India,” Tropical Medicine and International Health, vol. 11, no. 6, pp. 899–905, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Jacquet, M. Boelaert, J. Seaman et al., “Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL),” Tropical Medicine and International Health, vol. 11, no. 12, pp. 1777–1784, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. P. J. Hotez, J. H. F. Remme, P. Buss, G. Alleyne, C. Morel, and J. G. Breman, “Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project,” Clinical Infectious Diseases, vol. 38, no. 6, pp. 871–878, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Bern, A. W. Hightower, R. Chowdhury et al., “Risk factors for kala-azar in Bangladesh,” Emerging Infectious Diseases, vol. 11, no. 5, pp. 655–662, 2005. View at Google Scholar · View at Scopus
  30. S. Collin, R. Davidson, K. Ritmeijer et al., “Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan,” Clinical Infectious Diseases, vol. 38, no. 5, pp. 612–619, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. L. C. Rey, C. V. Martins, H. B. Ribeiro, and A. A. M. Lima, “American visceral leishmaniasis (kala-azar) in hospitalized children from an endemic area,” Jornal de Pediatria, vol. 81, no. 1, pp. 73–78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. E. E. Zijlstra, A. M. Musa, E. A. G. Khalil, I. M. El Hassan, and A. M. El-Hassan, “Post-kala-azar dermal leishmaniasis,” Lancet Infectious Diseases, vol. 3, no. 2, pp. 87–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. P. R. V. Desjeux, “Post-kala-azar dermal leishmaniasis: facing the challenge of eliminating kala-azar from South Asia,” in Kala Azar in South Asia: Current Status and Challenges Ahead, pp. 111–124, Springer Science + Business Media B.V., 2011. View at Google Scholar
  34. J. Alvar, P. Aparicio, A. Aseffa et al., “The relationship between leishmaniasis and AIDS: the second 10 years,” Clinical Microbiology Reviews, vol. 21, no. 2, pp. 334–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Reyburn, M. Rowland, M. Mohsen, B. Khan, and C. Davies, “The prolonged epidemic of anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: “Bringing down the neighbourgood”,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 97, no. 2, pp. 170–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Goto and J. A. L. Lindoso, “Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis,” Expert Review of Anti-Infective Therapy, vol. 8, no. 4, pp. 419–433, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. http://www.fp7-rapsodi.eu/150/.
  38. P. D. Marsden and W. H. Lumsden, “Trypanosomiasis and leishmaniasis,” Practitioner, vol. 207, no. 238, pp. 181–185, 1971. View at Google Scholar · View at Scopus
  39. R. S. Bray, “Leishmania,” Annual Review of Microbiology, vol. 28, pp. 189–217, 1974. View at Google Scholar
  40. D. M. Pratt and J. R. David, “Monoclonal antibodies that distinguish between New World species of Leishmania,” Nature, vol. 291, no. 5816, pp. 581–583, 1981. View at Google Scholar · View at Scopus
  41. L. Ryan, A. Vexenat, P. D. Marsden, R. Lainson, and J. J. Shaw, “The importance of rapid diagnosis of new cases of cutaneous leishmaniasis in pin-pointing the sandfly vector,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 84, no. 6, p. 786, 1990. View at Publisher · View at Google Scholar · View at Scopus
  42. D. E. Arnot and D. C. Barker, “Biochemical identification of cutaneous leishmanias by analysis of kinetoplast DNA. II. Sequence homologies in Leishmania kDNA,” Molecular and Biochemical Parasitology, vol. 3, no. 1, pp. 47–56, 1981. View at Google Scholar · View at Scopus
  43. M. A. Miles, R. Lainson, J. J. Shaw, M. Povoa, and A. A. de Souza, “Leishmaniasis in Brazil: XV. Biochemical distinction of Leishmania mexicana amazonensis, L. braziliensis braziliensis and L. braziliensis guyanensis—aetiological agents of cutaneous leishmaniasis in the Amazon Basin of Brazil,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 75, no. 4, pp. 524–529, 1981. View at Google Scholar · View at Scopus
  44. A. A. L. De Ibarra, J. G. Howard, and D. Snary, “Monoclonal antibodies to Leishmania tropica major: specificities and antigen location,” Parasitology, vol. 85, no. 3, pp. 523–531, 1982. View at Google Scholar · View at Scopus
  45. E. Handman and J. M. Curtis, “Leishmania tropica: surface antigens of intracellular and flagellate forms,” Experimental Parasitology, vol. 54, no. 2, pp. 243–249, 1982. View at Google Scholar · View at Scopus
  46. D. F. Wirth and D. M. Pratt, “Rapid identification of Leishmania species by specific hybridization of kinetoplast DNA in cutaneous lesions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 22, pp. 6999–7003, 1982. View at Google Scholar · View at Scopus
  47. G. C. Brainard and P. L. Podolin, “Near-ultraviolet radiation suppresses pineal melatonin content,” Endocrinology, vol. 119, no. 5, pp. 2201–2205, 1986. View at Google Scholar · View at Scopus
  48. S. M. Le Blancq and W. Peters, “Leishmania in the Old World: 2. Heterogeneity among L. tropica zymodemes,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 80, no. 1, pp. 113–119, 1986. View at Google Scholar · View at Scopus
  49. B. L. Travi, Y. Osorio, P. C. Melby, B. Chandrasekar, L. Arteaga, and N. G. Saravia, “Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp,” Infection and Immunity, vol. 70, no. 5, pp. 2288–2296, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. WHO, “Control of the Leishmaniasis,” Technical Report Series 793, 1990. View at Google Scholar
  51. I. L. Mauricio, J. R. Stothard, and M. A. Miles, “The strange case of Leishmania chagasi,” Parasitology Today, vol. 16, no. 5, pp. 188–189, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. N. L. Sharma, V. K. Mahajan, A. Kanga et al., “Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in Himachal Pradesh, India,” American Journal of Tropical Medicine and Hygiene, vol. 72, no. 6, pp. 819–824, 2005. View at Google Scholar · View at Scopus
  53. A. L. Bañuls, J. C. Dujardin, F. Guerrini et al., “Is Leishmania (Viannia) peruviana a distinct species? A MLEE/RAPD evolutionary genetics answer,” Journal of Eukaryotic Microbiology, vol. 47, no. 3, pp. 197–207, 2000. View at Google Scholar · View at Scopus
  54. J. Fraga, A. M. Montalvo, S. De Doncker, J. C. Dujardin, and G. Van der Auwera, “Phylogeny of Leishmania species based on the heat-shock protein 70 gene,” Infection, Genetics and Evolution, vol. 10, no. 2, pp. 238–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. H. W. Murray, J. D. Berman, C. R. Davies, and N. G. Saravia, “Advances in leishmaniasis,” The Lancet, vol. 366, no. 9496, pp. 1561–1577, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Deborggraeve, T. Laurent, D. Espinosa et al., “A simplified and standardized polymerase chain reaction format for the diagnosis of leishmaniasis,” Journal of Infectious Diseases, vol. 198, no. 10, pp. 1565–1572, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Vega-Lopez, “Diagnosis of cutaneous leishmaniasis,” Current Opinion in Infectious Diseases, vol. 16, pp. 97–101, 2003. View at Google Scholar
  58. S. N. Al-Hucheimi, B. A. Sultan, and M. A. Al-Dhalimi, “A comparative study of the diagnosis of Old World cutaneous leishmaniasis in Iraq by polymerase chain reaction and microbiologic and histopathologic methods,” International Journal of Dermatology, vol. 48, no. 4, pp. 404–408, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Siddig, H. Ghalib, D. C. Shillington, and E. A. Petersen, “Visceral leishmaniasis in the Sudan: comparative parasitological methods of diagnosis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 82, no. 1, pp. 66–68, 1988. View at Google Scholar · View at Scopus
  60. G. Srividya, A. Kulshrestha, R. Singh, and P. Salotra, “Diagnosis of visceral leishmaniasis: developments over the last decade,” Parasitology Research, vol. 110, pp. 1065–1078, 2012. View at Google Scholar
  61. A. M. Allahverdiyev, M. Bagirova, S. Uzun et al., “The value of a new microculture method for diagnosis of visceral leishmaniasis by using bone marrow and peripheral blood,” American Journal of Tropical Medicine and Hygiene, vol. 73, no. 2, pp. 276–280, 2005. View at Google Scholar · View at Scopus
  62. G. Sreenivas, N. A. Ansari, R. Singh et al., “Diagnosis of visceral leishmaniasis: comparative potential of amastigote antigen, recombinant antigen and PCR,” British Journal of Biomedical Science, vol. 59, no. 4, pp. 218–222, 2002. View at Google Scholar · View at Scopus
  63. D. Jacquet, M. Boelaert, J. Seaman et al., “Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL),” Tropical Medicine and International Health, vol. 11, no. 12, pp. 1777–1784, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Sundar, R. K. Singh, R. Maurya et al., “Serological diagnosis of Indian visceral leishmaniasis: direct agglutination test versus rK39 strip test,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 100, no. 6, pp. 533–537, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Boelaert, S. El-Safi, A. Hailu et al., “Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 102, no. 1, pp. 32–40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Kumar, K. Pai, K. Pathak, and S. Sundar, “Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis,” Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 6, pp. 1220–1224, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Srivastava, A. Dayama, S. Mehrotra, and S. Sundar, “Diagnosis of visceral leishmaniasis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 105, no. 1, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. P. Srivastava, S. Mehrotra, P. Tiwary, J. Chakravarty, and S. Sundar, “Diagnosis of indian visceral leishmaniasis by nucleic acid detection using PCR,” PLoS ONE, vol. 6, no. 4, article e19304, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Maurya, R. K. Singh, B. Kumar, P. Salotra, M. Rai, and S. Sundar, “Evaluation of PCR for diagnosis of Indian kala-azar and assessment of cure,” Journal of Clinical Microbiology, vol. 43, no. 7, pp. 3038–3041, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Kuhls, L. Keilonat, S. Ochsenreither et al., “Multilocus microsatellite typing (MLMT) reveals genetically isolated populations between and within the main endemic regions of visceral leishmaniasis,” Microbes and Infection, vol. 9, no. 3, pp. 334–343, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Dey and S. Singh, “Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India,” Infection, Genetics and Evolution, vol. 7, no. 2, pp. 219–222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. K. W. Q. Tintaya, X. Ying, J. P. Dedet, S. Rijal, X. De Bolle, and J. C. Dujardin, “Antigen genes for molecular epidemiology of leishmaniasis: polymorphism of cysteine proteinase B and surface metalloprotease glycoprotein 63 in the Leishmania donovani complex,” Journal of Infectious Diseases, vol. 189, no. 6, pp. 1035–1043, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. I. L. Mauricio, J. R. Stothard, and M. A. Miles, “Leishmania donovani complex: genotyping with the ribosomal internal transcribed spacer and the mini-exon,” Parasitology, vol. 128, no. 3, pp. 263–267, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. S. De Doncker, V. Hutse, S. Abdellati et al., “A new PCR-ELISA for diagnosis of visceral leishmaniasis in blood of HIV-negative subjects,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 99, no. 1, pp. 25–31, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Khosravi, S. H. Hejazi, M. Hashemzadeh, G. Eslami, and H. Y. Darani, “Molecular diagnosis of old world leishmaniasis: real-time PCR based on tryparedoxin peroxidase gene for the detection and identification of Leishmania spp,” Journal of Vector Borne Diseases, vol. 49, no. 1, pp. 15–18, 2012. View at Google Scholar
  76. E. E. Zijlstra, M. S. Ali, A. M. El-Hassan et al., “Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 86, no. 5, pp. 505–507, 1992. View at Publisher · View at Google Scholar · View at Scopus
  77. A. M. Allahverdiyev, M. Bagirova, S. Uzun et al., “The value of a new microculture method for diagnosis of visceral leishmaniasis by using bone marrow and peripheral blood,” American Journal of Tropical Medicine and Hygiene, vol. 73, no. 2, pp. 276–280, 2005. View at Google Scholar · View at Scopus
  78. F. Chappuis, S. Rijal, A. Soto, J. Menten, and M. Boelaert, “A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis,” British Medical Journal, vol. 333, no. 7571, pp. 723–726, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Gari-Toussaint, A. Leliévre, P. Marty, and Y. Le Fichoux, “Contribution of serological tests to the diagnosis of visceral leishmaniasis in patients infected with the human immunodeficiency virus,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 88, no. 3, pp. 301–302, 1994. View at Publisher · View at Google Scholar · View at Scopus
  80. H. D. F. H. Schallig, G. J. Schoone, C. C. M. Kroon, A. Hailu, F. Chappuis, and H. Veeken, “Development and application of 'simple' diagnostic tools for visceral leishmaniasis,” Medical Microbiology and Immunology, vol. 190, no. 1-2, pp. 69–71, 2001. View at Google Scholar · View at Scopus
  81. S. Sundar, R. K. Singh, R. Maurya et al., “Serological diagnosis of Indian visceral leishmaniasis: direct agglutination test versus rK39 strip test,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 100, no. 6, pp. 533–537, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. C. B. Palatnik-de-Sousa, E. M. Gomes, E. Paraguai-de-Souza, M. Palatnik, K. Luz, and R. Borojevic, “Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 4, pp. 390–393, 1995. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Kumar, K. Pai, K. Pathak, and S. Sundar, “Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis,” Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 6, pp. 1220–1224, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. R. L. Houghton, M. Petrescu, D. R. Benson et al., “A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy,” Journal of Infectious Diseases, vol. 177, no. 5, pp. 1339–1344, 1998. View at Google Scholar · View at Scopus
  85. T. M. Mohapatra, D. P. Singh, M. R. Sen, K. Bharti, and S. Sundar, “Comparative evaluation of rK9, rK26 and rK39 antigens in the serodiagnosis of Indian visceral leishmaniasis,” Journal of Infection in Developing Countries, vol. 4, no. 2, pp. 114–117, 2010. View at Google Scholar · View at Scopus
  86. F. Chappuis, Y. Mueller, A. Nguimfack et al., “Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda,” Journal of Clinical Microbiology, vol. 43, no. 12, pp. 5973–5977, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. F. Chappuis, S. Sundar, A. Hailu et al., “Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?” Nature Reviews Microbiology, vol. 5, no. 11, pp. 873–882, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. M. J. Pérez-Alvarez, R. Larreta, C. Alonso, and J. M. Requena, “Characterisation of a monoclonal antibody recognising specifically the HSP70 from Leishmania,” Parasitology Research, vol. 87, no. 11, pp. 907–910, 2001. View at Google Scholar · View at Scopus
  89. R. Piarroux, F. Gambarelli, H. Dumon et al., “Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral leishmaniasis in immunocompromised patients,” Journal of Clinical Microbiology, vol. 32, no. 3, pp. 746–749, 1994. View at Google Scholar · View at Scopus
  90. S. De Doncker, V. Hutse, S. Abdellati et al., “A new PCR-ELISA for diagnosis of visceral leishmaniasis in blood of HIV-negative subjects,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 99, no. 1, pp. 25–31, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. R. K. Singh, H. P. Pandey, and S. Sundar, “Visceral leishmaniasis (kala-azar): challenges ahead,” Indian Journal of Medical Research, vol. 123, no. 3, pp. 331–344, 2006. View at Google Scholar · View at Scopus
  92. T. K. Jha, “Evaluation of diamidine compound (pentamidine isethionate) in the treatment of resistant cases of kala-azar occurring in North Bihar, India,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 77, no. 2, pp. 167–170, 1983. View at Google Scholar · View at Scopus
  93. S. N. Jha, N. K. Singh, and T. K. Jha, “Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial,” The Journal of the Association of Physicians of India, vol. 39, no. 4, pp. 314–316, 1991. View at Google Scholar · View at Scopus
  94. S. Sundar, “Treatment of visceral leishmaniasis,” Medical Microbiology and Immunology, vol. 190, no. 1-2, pp. 89–92, 2001. View at Google Scholar · View at Scopus
  95. S. L. Croft and V. Yardley, “Chemotherapy of leishmaniasis,” Current Pharmaceutical Design, vol. 8, no. 4, pp. 319–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Jhingran, B. Chawla, S. Saxena, M. P. Barrett, and R. Madhubala, “Paromomycin: uptake and resistance in Leishmania donovani,” Molecular and Biochemical Parasitology, vol. 164, no. 2, pp. 111–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. N. Singh, M. Kumar, and R. K. Singh, “Leishmaniasis: current status of available drugs and new potential drug targets,” Asian Pacific Journal of Tropical Medicine, vol. 5, no. 6, pp. 485–497, 2012. View at Google Scholar
  98. A. Rochette, F. Raymond, J. M. Ubeda et al., “Genome-wide gene expression profiling analysis of Leishmania major and Leishmania infantum developmental stages reveals substantial differences between the two species,” BMC Genomics, vol. 9, pp. 255–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Krieger, W. Schwarz, M. R. Arlyanayagam, A. H. Fairlamb, R. L. Krauth-Siegel, and C. Clayton, “Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress,” Molecular Microbiology, vol. 35, no. 3, pp. 542–552, 2000. View at Publisher · View at Google Scholar · View at Scopus
  100. D. B. Castro-Pinto, M. Genestra, G. B. Menezes et al., “Cloning and expression of trypanothione reductase from a New World Leishmania species,” Archives of Microbiology, vol. 189, no. 4, pp. 375–384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. R. F. Rodrigues, D. Castro-Pinto, A. Echevarria et al., “Investigation of trypanothione reductase inhibitory activity by 1, 3, 4- thiadiazolium-2-aminide derivatives and molecular docking studies,” Bioorganic & Medicinal Chemistry, vol. 20, no. 5, pp. 1760–1766, 2012. View at Google Scholar
  102. P. Ascenzi, A. Bocedi, P. Visca, G. Antonini, and L. Gradoni, “Catalytic properties of cysteine proteinases from Trypanosoma cruzi and Leishmania infantum: a pre-steady-state and steady-state study,” Biochemical and Biophysical Research Communications, vol. 309, no. 3, pp. 659–665, 2003. View at Publisher · View at Google Scholar · View at Scopus
  103. S. O. Lorente, R. Gómez, C. Jiménez et al., “Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa,” Bioorganic and Medicinal Chemistry, vol. 13, no. 10, pp. 3519–3529, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. P. Bhargava, K. Kumar, S. S. Chaudhaery, A. K. Saxena, and U. Roy, “Cloning, overexpression and characterization of Leishmania donovani squalene synthase,” FEMS Microbiology Letters, vol. 311, no. 1, pp. 82–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. J. A. Urbina, J. L. Concepcion, S. Rangel, G. Visbal, and R. Lira, “Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana,” Molecular and Biochemical Parasitology, vol. 125, no. 1-2, pp. 35–45, 2002. View at Google Scholar · View at Scopus
  106. C. Jiménez-Jiménez, J. Carrero-Lérida, M. Sealey-Cardona, L. M. Ruiz-Pérez, J. A. Urbina, and D. González-Pacanowska, “Δ24 (25)-sterol methenyltransferase: intracellular localization and azasterol sensitivity in Leishmania major promastigotes overexpressing the enzyme,” Molecular and Biochemical Parasitology, vol. 160, no. 1, pp. 52–59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. C. W. Roberts, R. McLeod, D. W. Rice, M. Ginger, M. L. Chance, and L. J. Goad, “Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa,” Molecular and Biochemical Parasitology, vol. 126, no. 2, pp. 129–142, 2003. View at Publisher · View at Google Scholar · View at Scopus
  108. O. Heby, L. Persson, and R. Madhubala, “Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis,” Amino Acids, vol. 33, no. 2, pp. 359–366, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. V. Iniesta, L. C. Gómez-Nieto, and I. Corraliza, “The inhibition of arginase by Nω-hydroxy-L-arginine controls the growth of Leishmania inside macrophages,” Journal of Experimental Medicine, vol. 193, no. 6, pp. 777–783, 2001. View at Publisher · View at Google Scholar · View at Scopus
  110. R. Balana-Fouce, E. Calvo-Álvarez, R. Álvarez-Velilla, C. F. Prada, Y. Pérez-Pertejo, and R. M. Reguera, “Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis,” Molecular and Biochemical Parasitology, vol. 181, no. 2, pp. 85–93, 2012. View at Google Scholar
  111. B. M. Bakker, F. I. C. Mensonides, B. Teusink, P. Van Hoek, P. A. M. Michels, and H. V. Westerhoff, “Compartmentation protects trypanosomes from the dangerous design of glycolysis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 5, pp. 2087–2092, 2000. View at Publisher · View at Google Scholar · View at Scopus
  112. P. A. M. Michels, V. Hannaert, and F. Bringaud, “Metabolic aspects of glycosomes in Trypanosomatidae—new data and views,” Parasitology Today, vol. 16, no. 11, pp. 482–489, 2000. View at Publisher · View at Google Scholar · View at Scopus
  113. P. Hassan, D. Fergusson, K. M. Grant, and J. C. Mottram, “The CRK3 protein kinase is essential for cell cycle progression of Leishmania mexicana,” Molecular and Biochemical Parasitology, vol. 113, no. 2, pp. 189–198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  114. K. M. Grant, M. H. Dunion, V. Yardley et al., “Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 8, pp. 3033–3042, 2004. View at Publisher · View at Google Scholar · View at Scopus
  115. E. Xingi, D. Smirlis, V. Myrianthopoulos et al., “6-Br-5methylindirubin-3′oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis,” International Journal for Parasitology, vol. 39, no. 12, pp. 1289–1303, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. P. H. Liang and K. S. Anderson, “Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase,” Biochemistry, vol. 37, no. 35, pp. 12195–12205, 1998. View at Publisher · View at Google Scholar · View at Scopus
  117. O. Senkovich, N. Schormann, and D. Chattopadhyay, “Structures of dihydrofolate reductase-thymidylate synthase of trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate,” Acta Crystallographica Section D, vol. 65, no. 7, pp. 704–716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. F. Zuccotto, A. C. R. Martin, R. A. Laskowski, J. M. Thornton, and I. H. Gilbert, “Dihydrofolate reductase: a potential drug target in trypanosomes and leishmania,” Journal of Computer-Aided Molecular Design, vol. 12, no. 3, pp. 241–257, 1998. View at Google Scholar · View at Scopus
  119. I. D. Kuntz, “Structure-based strategies for drug design and discovery,” Science, vol. 257, no. 5073, pp. 1078–1082, 1992. View at Google Scholar · View at Scopus
  120. P. S. T. Veras, C. I. Brodskyn, F. M. P. Balestieri et al., “A dhfr-ts- Leishmania major Knockout Mutant Cross-protects against Leishmania amazonensis,” Memorias do Instituto Oswaldo Cruz, vol. 94, no. 4, pp. 491–496, 1999. View at Google Scholar · View at Scopus
  121. F. Fonseca-Silva, J. D. F. Inacio, M. M. Canto-Cavalheiro, and E. E. Almeida-Amaral, “Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis,” PLoS ONE, vol. 6, no. 2, article e14666, 2011. View at Publisher · View at Google Scholar · View at Scopus